April 15, 2025 – DESKi recently announced FDA clearance for HeartFocus, its AI-enabled heart exam software that empowers ...
On April 9, 2025, the world’s first multisector advocacy movement dedicated to stroke — the Global Stroke Action ...
April 1, 2025 — UltraSight recently announced the presentation at the American College of Cardiology (ACC) Annual ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

Cardiology practices face mounting financial pressures — rising operational costs, declining reimbursements, and complex ...
April 10, 2025 — The American College of Cardiology’s (ACC’s) five-year Strategic Plan includes a major initiative ...
April 9, 2025 — Idorsia Ltd recently announced that the US Food & Drug Administration (FDA), after having released ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
April 7, 2025 — CardioVia, a medical device company specializing in advanced cardiac care solutions, has received U.S ...
April 4, 2025 — Viz.ai has been named an Award Winner in the 2025 Edison Awards, for the third year in a row. Viz HCM ...
April 3, 2025 — Tower Health and Siemens Healthineers recently announced a 10-year agreement focused on equipment ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 31, 2025 — Using intravascular imaging (IVI) to guide stent implantation during complex stenting procedures is ...
March 31, 2025 -— BioCardia, Inc. recently announced two-year outcomes from the double-blind randomized placebo ...
March 30, 2025 — Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
March 31, 2025 — iRhythm Technologies, Inc. has announced results from two large real-world retrospective analyses ...
March 31, 2025 — AGEPHA Pharma USA, LLC, has highlighted clinical data that provides new information about how low-dose ...
March 29, 2025 — Anthos Therapeutics, Inc., presented two new analyses from its AZALEA-TIMI 71 study at the American ...